204 related articles for article (PubMed ID: 10644067)
1. Vitamin E-TPGS increases absorption flux of an HIV protease inhibitor by enhancing its solubility and permeability.
Yu L; Bridgers A; Polli J; Vickers A; Long S; Roy A; Winnike R; Coffin M
Pharm Res; 1999 Dec; 16(12):1812-7. PubMed ID: 10644067
[TBL] [Abstract][Full Text] [Related]
2. Enhanced oral paclitaxel absorption with vitamin E-TPGS: effect on solubility and permeability in vitro, in situ and in vivo.
Varma MV; Panchagnula R
Eur J Pharm Sci; 2005; 25(4-5):445-53. PubMed ID: 15890503
[TBL] [Abstract][Full Text] [Related]
3. Intraluminal drug and formulation behavior and integration in in vitro permeability estimation: a case study with amprenavir.
Brouwers J; Tack J; Lammert F; Augustijns P
J Pharm Sci; 2006 Feb; 95(2):372-83. PubMed ID: 16374852
[TBL] [Abstract][Full Text] [Related]
4. Effect of tocopheryl polyethylene glycol succinate on the percutaneous penetration of minoxidil from water/ethanol/polyethylene glycol 400 solutions.
Sheu MT; Wu AB; Lin KP; Shen CH; Ho HO
Drug Dev Ind Pharm; 2006 Jun; 32(5):595-607. PubMed ID: 16720414
[TBL] [Abstract][Full Text] [Related]
5. Role of P-glycoprotein on the CNS disposition of amprenavir (141W94), an HIV protease inhibitor.
Polli JW; Jarrett JL; Studenberg SD; Humphreys JE; Dennis SW; Brouwer KR; Woolley JL
Pharm Res; 1999 Aug; 16(8):1206-12. PubMed ID: 10468021
[TBL] [Abstract][Full Text] [Related]
6. Influence of vitamin E TPGS poly(ethylene glycol) chain length on apical efflux transporters in Caco-2 cell monolayers.
Collnot EM; Baldes C; Wempe MF; Hyatt J; Navarro L; Edgar KJ; Schaefer UF; Lehr CM
J Control Release; 2006 Mar; 111(1-2):35-40. PubMed ID: 16410030
[TBL] [Abstract][Full Text] [Related]
7. In vitro behavior of a phosphate ester prodrug of amprenavir in human intestinal fluids and in the Caco-2 system: illustration of intraluminal supersaturation.
Brouwers J; Tack J; Augustijns P
Int J Pharm; 2007 May; 336(2):302-9. PubMed ID: 17207947
[TBL] [Abstract][Full Text] [Related]
8. P-glycoprotein and surfactants: effect on intestinal talinolol absorption.
Bogman K; Zysset Y; Degen L; Hopfgartner G; Gutmann H; Alsenz J; Drewe J
Clin Pharmacol Ther; 2005 Jan; 77(1):24-32. PubMed ID: 15637528
[TBL] [Abstract][Full Text] [Related]
9. Influence of vitamin E tocopherol polyethylene glycol succinate 1000 on intestinal absorption of icariside II.
Zhang Z; Lv H; Jia X; Lingling C; Xin J; Yan C; Tan X; Sun E
Pharmazie; 2012 Jan; 67(1):59-62. PubMed ID: 22393832
[TBL] [Abstract][Full Text] [Related]
10. Stereoselective and concentration-dependent polarized epithelial permeability of a series of phosphoramidate triester prodrugs of d4T: an in vitro study in Caco-2 and Madin-Darby canine kidney cell monolayers.
Siccardi D; Kandalaft LE; Gumbleton M; McGuigan C
J Pharmacol Exp Ther; 2003 Dec; 307(3):1112-9. PubMed ID: 14557377
[TBL] [Abstract][Full Text] [Related]
11. Concomitant solubility-permeability increase: Vitamin E TPGS vs. amorphous solid dispersion as oral delivery systems for etoposide.
Beig A; Fine-Shamir N; Porat D; Lindley D; Miller JM; Dahan A
Eur J Pharm Biopharm; 2017 Dec; 121():97-103. PubMed ID: 28958946
[TBL] [Abstract][Full Text] [Related]
12. Assessment of active transport of HIV protease inhibitors in various cell lines and the in vitro blood--brain barrier.
van der Sandt IC; Vos CM; Nabulsi L; Blom-Roosemalen MC; Voorwinden HH; de Boer AG; Breimer DD
AIDS; 2001 Mar; 15(4):483-91. PubMed ID: 11242145
[TBL] [Abstract][Full Text] [Related]
13. Enhanced oral bioavailability of paclitaxel by D-alpha-tocopheryl polyethylene glycol 400 succinate in mice.
Ho PY; Yeh TK; Yao HT; Lin HL; Wu HY; Lo YK; Chang YW; Chiang TH; Wu SH; Chao YS; Chen CT
Int J Pharm; 2008 Jul; 359(1-2):174-81. PubMed ID: 18513900
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of P-glycoprotein by D-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS).
Dintaman JM; Silverman JA
Pharm Res; 1999 Oct; 16(10):1550-6. PubMed ID: 10554096
[TBL] [Abstract][Full Text] [Related]
15. Improved oral bioavailability of fexofenadine hydrochloride using lipid surfactants: ex vivo, in situ and in vivo studies.
Eedara BB; Veerareddy PR; Jukanti R; Bandari S
Drug Dev Ind Pharm; 2014 Aug; 40(8):1030-43. PubMed ID: 23738504
[TBL] [Abstract][Full Text] [Related]
16. Inhibiting efflux with novel non-ionic surfactants: Rational design based on vitamin E TPGS.
Wempe MF; Wright C; Little JL; Lightner JW; Large SE; Caflisch GB; Buchanan CM; Rice PJ; Wacher VJ; Ruble KM; Edgar KJ
Int J Pharm; 2009 Mar; 370(1-2):93-102. PubMed ID: 19100824
[TBL] [Abstract][Full Text] [Related]
17. Influence of micelle solubilization by tocopheryl polyethylene glycol succinate (TPGS) on solubility enhancement and percutaneous penetration of estradiol.
Sheu MT; Chen SY; Chen LC; Ho HO
J Control Release; 2003 Mar; 88(3):355-68. PubMed ID: 12644362
[TBL] [Abstract][Full Text] [Related]
18. Tabletability assessment of conventional formulations containing Vitamin E tocopheryl polyethylene glycol succinate.
Jin F; Tatavarti A
Int J Pharm; 2010 Apr; 389(1-2):58-65. PubMed ID: 20083178
[TBL] [Abstract][Full Text] [Related]
19. Mechanistic study of solubility enhancement of nifedipine using vitamin E TPGS or solutol HS-15.
Rajebahadur M; Zia H; Nues A; Lee C
Drug Deliv; 2006; 13(3):201-6. PubMed ID: 16556572
[TBL] [Abstract][Full Text] [Related]
20. Improvement of the bioavailability of colchicine in rats by co-administration of D-alpha-tocopherol polyethylene glycol 1000 succinate and a polyethoxylated derivative of 12-hydroxy-stearic acid.
Bittner B; Guenzi A; Fullhardt P; Zuercher G; González RC; Mountfield RJ
Arzneimittelforschung; 2002; 52(9):684-8. PubMed ID: 12404883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
